Found: 23
Select item for more details and to access through your institution.
Nerve growth factor promotes lysyl oxidase-dependent chondrosarcoma cell metastasis by suppressing miR-149-5p synthesis.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 12, p. 1, doi. 10.1038/s41419-021-04392-2
- By:
- Publication type:
- Article
Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0197851
- By:
- Publication type:
- Article
Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.592415
- By:
- Publication type:
- Article
CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin αvβ3 Axis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 23, p. 12737, doi. 10.3390/ijms222312737
- By:
- Publication type:
- Article
Visfatin Promotes the Metastatic Potential of Chondrosarcoma Cells by Stimulating AP-1-Dependent MMP-2 Production in the MAPK Pathway.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8642, doi. 10.3390/ijms22168642
- By:
- Publication type:
- Article
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 652, doi. 10.1159/000517738
- By:
- Publication type:
- Article
Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02464-x
- By:
- Publication type:
- Article
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 2, p. 349, doi. 10.1002/cam4.969
- By:
- Publication type:
- Article
Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography‐staged esophageal squamous cell carcinoma after complete resection: A population‐based cohort study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 13, p. 1986, doi. 10.1111/1759-7714.14476
- By:
- Publication type:
- Article
Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study.
- Published in:
- Technology in Cancer Research & Treatment, 2022, v. 21, p. 1, doi. 10.1177/15330338221107714
- By:
- Publication type:
- Article
Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society registry database.
- Published in:
- Head & Neck, 2024, v. 46, n. 5, p. 1063, doi. 10.1002/hed.27681
- By:
- Publication type:
- Article
Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 1, p. 149, doi. 10.1007/s12185-022-03445-2
- By:
- Publication type:
- Article
Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 4, p. 525, doi. 10.1007/s12185-021-03280-x
- By:
- Publication type:
- Article
The Chemokine CCL4 Stimulates Angiopoietin-2 Expression and Angiogenesis via the MEK/ERK/STAT3 Pathway in Oral Squamous Cell Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071612
- By:
- Publication type:
- Article
B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.879398
- By:
- Publication type:
- Article
Programmed Death Ligand-1 and Tumor Burden Score Dictate Treatment Responses in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1748, doi. 10.3390/cancers16091748
- By:
- Publication type:
- Article
Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6205, doi. 10.3390/cancers14246205
- By:
- Publication type:
- Article
Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1097, doi. 10.3390/cancers14041097
- By:
- Publication type:
- Article
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the miR-153-3p/Snail Axis.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1903, doi. 10.3390/cancers11121903
- By:
- Publication type:
- Article
Interleukin‐11/gp130 upregulates MMP‐13 expression and cell migration in OSCC by activating PI3K/Akt and AP‐1 signaling.
- Published in:
- Journal of Cellular Physiology, 2022, v. 237, n. 12, p. 4551, doi. 10.1002/jcp.30902
- By:
- Publication type:
- Article
Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08).
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 51, doi. 10.1007/s11523-023-01028-7
- By:
- Publication type:
- Article
A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 71, doi. 10.1007/s11523-023-01018-9
- By:
- Publication type:
- Article